ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 625495 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 625495; 2) Community: the network communities that were significantly associated with the response to NSC 625495; 3) Molecule: the relationships between components within communities and NSC 625495; 4) MDR: the compounds that were significantly associated with the NSC 625495.

NSC Compound Enrichment Correlation
NSC 754109 ethyl 8-(3-methoxybenzyl)-5,8-dihydro-4H-isoxazolo[4,5-g]indole-7-carboxylate 0.0135714101922724 0.40434406
NSC 357288 LIATRIS LAEVIGATA LACTONE #2 0.0135714101922725 0.41348522
NSC 627506 Null 0.0138010872611484 0.29165961
NSC 627618 Null 0.0138010872611484 0.43593017
NSC 627787 2,3-Dimethoxy-12,12a-dihydro-12-oxodibenzo[b,g] indoloisoquinolinium sulfate 0.0138010872611484 0.044423336
NSC 633268 Null 0.0138010872611484 0.48354414
NSC 633273 ANTINEOPLASTIC-633273 0.0138010872611484 0.41656048
NSC 633685 9-N-(N'-chloroethyl-N'-1,6-diaminohexyl) 2-methoxyacridine, dihydrochloride 0.0138010872611484 0.59560785
NSC 639518 Cyclopentanone, 2-[[4-(benzoyloxy)-3-methoxyphenyl] methylene]-5-[(dimethylamino)methyl]-, hydrochloride 0.0138010872611484 0.54013292
NSC 651855 Null 0.0138010872611484 0.16126128
Total:101  Current:35    [First] [Prev] [Next] [Last]